APA (7th ed.) Citation

Schenck Eidam, H., Russell, J., Raha, K., DeMartino, M., Qin, D., Guan, H. A., . . . Cheung, M. (2018). Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS. ACS medicinal chemistry letters, 9(7), 623-628. https://doi.org/10.1021/acsmedchemlett.8b00035

Chicago Style (17th ed.) Citation

Schenck Eidam, Hilary, et al. "Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS." ACS Medicinal Chemistry Letters 9, no. 7 (2018): 623-628. https://doi.org/10.1021/acsmedchemlett.8b00035.

MLA (9th ed.) Citation

Schenck Eidam, Hilary, et al. "Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS." ACS Medicinal Chemistry Letters, vol. 9, no. 7, 2018, pp. 623-628, https://doi.org/10.1021/acsmedchemlett.8b00035.